Hepatocellular carcinoma (HCC) is the fifth most common malignancy worldwide imposing high hospitalizations and mortality rates and a relevant economic burden. Objective of the present analysis is to investigate treatment pathways and healthcare costs for intermediate and advanced HCC patients (Barcelona Clinic Liver Cancer Classification (BCLC) stage B and C). M
Intermediate and Advanced Hepatocellular Carcinoma Management in four Italian Centers: Patterns of Treatment and Costs / Colombo, Gl; Cammà, C; Attili, Adolfo Francesco; Ganga, R; Gaeta, Gb; Brancaccio, G; Franzini, Jm; Volpe, M; Cortesi, Enrico; Turchetti, G.. - In: VALUE IN HEALTH. - ISSN 1098-3015. - ELETTRONICO. - (2015). [10.1016/j.jval.2015.09.1141]
Intermediate and Advanced Hepatocellular Carcinoma Management in four Italian Centers: Patterns of Treatment and Costs.
ATTILI, Adolfo Francesco;CORTESI, Enrico;
2015
Abstract
Hepatocellular carcinoma (HCC) is the fifth most common malignancy worldwide imposing high hospitalizations and mortality rates and a relevant economic burden. Objective of the present analysis is to investigate treatment pathways and healthcare costs for intermediate and advanced HCC patients (Barcelona Clinic Liver Cancer Classification (BCLC) stage B and C). M| File | Dimensione | Formato | |
|---|---|---|---|
|
Colombo_intermediate-hepatocellular_2016.pdf
accesso aperto
Tipologia:
Documento in Post-print (versione successiva alla peer review e accettata per la pubblicazione)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
69.54 kB
Formato
Adobe PDF
|
69.54 kB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
